Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.

Authors

Clare J Twist
Arlene Naranjo
Mary Lou Schmidt
Sheena C Tenney
Susan L Cohn
Holly J Meany, George Washington University
Peter Mattei
E Stanton Adkins
Hiroyuki Shimada
Wendy B London
Julie R Park
Katherine K Matthay
John M Maris

Document Type

Journal Article

Publication Date

11-16-2018

Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

DOI

10.1200/JCO.18.00419

Comments

Epub ahead of print

APA Citation

Twist, C., Naranjo, A., Schmidt, M., Tenney, S., Cohn, S., Meany, H., Mattei, P., Adkins, E., Shimada, H., London, W., Park, J., Matthay, K., & Maris, J. (2018). Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, (). http://dx.doi.org/10.1200/JCO.18.00419

Peer Reviewed

1